This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DaVita Partners With Leading Physicians In Germany

DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced a partnership with one of Germany’s most renowned nephrology practices to deliver leading renal care to patients in Düsseldorf.

Praxis mit Nähe joins DaVita along with its world-class physicians including Prof. Werner Kleophas, Dr. Andreas Westhoff, Prof. Gerd Hetzel and Prof. Frank Dellanna.

“The addition of this highly regarded practice is an exciting opportunity for DaVita and represents a key step in our long-term growth strategy in Europe,” said Dennis Kogod, chief operating officer of DaVita HealthCare Partners SM.

“DaVita brings a model to Germany that wonderfully aligns with the values our practice has held for more than 30 years,” said Prof. Werner Kleophas. “Being product independent, DaVita’s sole focus is on perfection in kidney care delivery and putting patients first. We’ve always cherished independence and liberty in treatment and together with DaVita we believe we can accomplish great results in the delivery of care for our patients in Düsseldorf.”

Praxis mit Nähe has six Düsseldorf-based clinics specializing in dialysis, nephrology and diabetology and was one of the largest privately held groups in Germany. The partnership more than doubles DaVita’s footprint in Germany with a current total number of ten centers.

“When DaVita entered Germany two years ago, our aim was to improve quality of life for the country’s kidney care patients,” said Bjӧrn Englund, president of DaVita’s Europe and Middle East operations. “Having these esteemed doctors join DaVita is a testament to the strides we’ve made and positions DaVita as the partner and provider of choice in German kidney care.”

DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs